Healthcare provider profile · identity verified

Ty L Gore, M.D.

Family Practice · MINERAL WELLS, TX · NPI 1578544698

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	400	88
Levothyroxine Sodium	Levothyroxine Sodium	362	78
Atorvastatin Calcium	Atorvastatin Calcium	335	87
Pantoprazole Sodium	Pantoprazole Sodium	286	75
Gabapentin	Gabapentin	278	59
Metoprolol Succinate	Metoprolol Succinate	273	72
Alprazolam	Alprazolam	272	53
Metformin Hcl	Metformin Hcl	266	65
Hydrochlorothiazide	Hydrochlorothiazide	258	59
Amlodipine Besylate	Amlodipine Besylate	217	56
Rosuvastatin Calcium	Rosuvastatin Calcium	214	57
Lisinopril	Lisinopril	211	57
Montelukast Sodium	Montelukast Sodium	191	43
Famotidine	Famotidine	175	47
Tamsulosin Hcl	Tamsulosin Hcl	164	42
Sertraline Hcl	Sertraline Hcl	157	41
Azithromycin	Azithromycin	156	102
Potassium Chloride	Potassium Chloride	141	38
Cephalexin	Cephalexin	131	94
Pravastatin Sodium	Pravastatin Sodium	129	35
Allopurinol	Allopurinol	127	33
Eliquis	Apixaban	118	20
Glipizide	Glipizide	95	25
Omeprazole	Omeprazole	95	26
Escitalopram Oxalate	Escitalopram Oxalate	89	26
Albuterol Sulfate Hfa	Albuterol Sulfate	87	38
Metoprolol Tartrate	Metoprolol Tartrate	86	26
Fluticasone Propionate	Fluticasone Propionate	81	30
Simvastatin	Simvastatin	81	23
Duloxetine Hcl	Duloxetine Hcl	76	13
Trazodone Hcl	Trazodone Hcl	74	20
Ozempic	Semaglutide	70	11
Clopidogrel	Clopidogrel Bisulfate	68	19
Furosemide	Furosemide	66	20
Prednisone	Prednisone	62	42
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	59	13
Pregabalin	Pregabalin	57	11
Tramadol Hcl	Tramadol Hcl	57	19
Citalopram Hbr	Citalopram Hydrobromide	56	13
Zolpidem Tartrate	Zolpidem Tartrate	55	11
Xarelto	Rivaroxaban	54	suppressed
Atenolol	Atenolol	53	14
Doxazosin Mesylate	Doxazosin Mesylate	53	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	13
Januvia	Sitagliptin Phosphate	50	15
Buspirone Hcl	Buspirone Hcl	49	12
Fluoxetine Hcl	Fluoxetine Hcl	49	suppressed
Ondansetron Hcl	Ondansetron Hcl	48	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	45	39
Amitriptyline Hcl	Amitriptyline Hcl	44	12
Finasteride	Finasteride	44	12
Tizanidine Hcl	Tizanidine Hcl	42	11
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Digoxin	Digoxin	38	suppressed
Nebivolol Hcl	Nebivolol Hcl	38	suppressed
Carvedilol	Carvedilol	37	11
Estradiol	Estradiol	36	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	35	11
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Meloxicam	Meloxicam	30	11
Azelastine Hcl	Azelastine Hcl	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	28	suppressed
Clonazepam	Clonazepam	28	suppressed
Lansoprazole	Lansoprazole	28	suppressed
Ibandronate Sodium	Ibandronate Sodium	27	suppressed
Fluconazole	Fluconazole	26	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Methylprednisolone	Methylprednisolone	23	20
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	14
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Jardiance	Empagliflozin	20	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Testosterone Cypionate	Testosterone Cypionate	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Indapamide	Indapamide	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	17	suppressed
Acyclovir	Acyclovir	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Ranolazine Er	Ranolazine	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Bicalutamide	Bicalutamide	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	13	suppressed
Topiramate	Topiramate	13	suppressed
Briviact	Brivaracetam	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Exemestane	Exemestane	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Risperidone	Risperidone	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Valsartan	Valsartan	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Primidone	Primidone	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error